BLZF1 expression is of prognostic significance in hepatocellular carcinoma
- PMID: 26342799
- DOI: 10.1016/j.bbrc.2015.08.119
BLZF1 expression is of prognostic significance in hepatocellular carcinoma
Abstract
BLZF1, a member of b-ZIP family, has been implicated in epigenetic regulation and Wnt/β-catenin signaling. Its expression and clinical significance in human cancers remain largely unknown. In this study, we showed that BLZF1 expression was reduced in hepatocellular carcinoma (HCC) tissues, compared to the paracarcinoma tissues, at both mRNA and protein levels. Results of immunohistochemistry revealed that BLZF1 was presented in both nuclear and cytoplasm. Decreased expression of nuclear and cytosolic BLZF1 in HCC was depicted in 68.2% and 79.2% of the 634 cases. Nuclear BLZF1 expression was significantly associated with tumor multiplicity (P = 0.048) and tumor capsule (P = 0.028), while cytosolic BLZF1 expression was correlated with serum AFP level (P = 0.017), tumor differentiation (P = 0.001) and tumor capsule (P = 0.003). Kaplan-Meier analysis indicated both nuclear and cytosolic BLZF1 expression was associated with poor overall survival. Low nuclear BLZF1 also indicated unfavorable disease-free survival and high tendency of tumor recurrence. Furthermore, multiple Cox regression analysis revealed nuclear BLZF1 as an independent factor for overall survival (Hazard Ratio (HR) = 0.827, 95% confident interval (95%CI): 0.697-0.980, P = 0.029). The prognostic value of BLZF1 was further confirmed by stratified analyses. Collectively, our data suggest BLZF1 is a novel unfavorable biomarker for prognosis of patients with HCC.
Keywords: BLZF1; Hepatocellular carcinoma; Immunohistochemistry; Prognosis.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma.J Korean Med Sci. 2015 Sep;30(9):1253-9. doi: 10.3346/jkms.2015.30.9.1253. Epub 2015 Aug 13. J Korean Med Sci. 2015. PMID: 26339164 Free PMC article.
-
Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983. World J Gastroenterol. 2015. PMID: 25852285 Free PMC article.
-
Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9. J Hepatol. 2009. PMID: 19303159
-
Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794190. doi: 10.1177/1533033818794190. Technol Cancer Res Treat. 2018. PMID: 30198401 Free PMC article.
-
Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.Int J Oncol. 2002 Apr;20(4):769-75. Int J Oncol. 2002. PMID: 11894123
Cited by
-
Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.PLoS One. 2022 Sep 21;17(9):e0274463. doi: 10.1371/journal.pone.0274463. eCollection 2022. PLoS One. 2022. PMID: 36129940 Free PMC article.
-
Structural Basis for the Interaction between Golgi Reassembly-stacking Protein GRASP55 and Golgin45.J Biol Chem. 2017 Feb 17;292(7):2956-2965. doi: 10.1074/jbc.M116.765990. Epub 2017 Jan 3. J Biol Chem. 2017. PMID: 28049725 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical